{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T09:40:13Z","timestamp":1730713213930,"version":"3.28.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.eimce.2024.09.006","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T10:47:23Z","timestamp":1728557243000},"page":"507-511","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and clinical-epidemiological characteristics of chronic hepatitis due to hepatitis delta virus on Gran Canaria Island"],"prefix":"10.1016","volume":"42","author":[{"given":"Goretti","family":"Redondo Betancor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melisa","family":"Hern\u00e1ndez Febles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Zaragoz\u00e1 Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Granados Monz\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ildefonso","family":"Qui\u00f1ones Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolfo","family":"de Salazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Garc\u00eda Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Pena L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimce.2024.09.006_bib0005","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/gutjnl-2018-316601","article-title":"Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis","volume":"68","author":"Chen","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.eimce.2024.09.006_bib0010","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jhep.2020.04.008","article-title":"The global prevalence of hepatitis D virus infection: systematic review and meta-analysis","volume":"73","author":"Stockdale","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.eimce.2024.09.006_bib0015","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1093\/infdis\/jiz633","article-title":"Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection","volume":"221","author":"Miao","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimce.2024.09.006_bib0020","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.eimce.2024.09.006_bib0025","doi-asserted-by":"crossref","first-page":"100547","DOI":"10.1016\/j.jhepr.2022.100547","article-title":"Implementation of anti-HDV reflex testing among HBsAg-positive individuals increases testing for hepatitis D","volume":"4","author":"Palom","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.eimce.2024.09.006_bib0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcv.2015.02.011","article-title":"Hepatitis delta virus testing, epidemiology and management: a multicentre cross-sectional study of patients in London","volume":"66","author":"El Bouzidi","year":"2015","journal-title":"J Clin Virol"},{"key":"10.1016\/j.eimce.2024.09.006_bib0035","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/liv.15746","article-title":"Anti-HDV reflex testing in HBsAg-positive subjects: an efficacious strategy to identify HDV infection","volume":"44","author":"Cossiga","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.eimce.2024.09.006_bib0040","first-page":"e1","article-title":"Segundo estudio de seroprevalencia en Espa\u00f1a; 2017\u20132018","volume":"95","author":"Limia","year":"2021","journal-title":"Rev Esp Salud Publica"},{"key":"10.1016\/j.eimce.2024.09.006_bib0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/liv.14357","article-title":"New epidemiology of hepatitis delta","volume":"40 Suppl. 1","author":"Vlachogiannakos","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.eimce.2024.09.006_bib0050","doi-asserted-by":"crossref","first-page":"104932","DOI":"10.1016\/j.jcv.2021.104932","article-title":"Reliable quantification of plasma HDV RNA is of paramount importance for treatment monitoring: a European multicenter study","volume":"142","author":"Stelzl","year":"2021","journal-title":"J Clin Virol"},{"key":"10.1016\/j.eimce.2024.09.006_bib0055","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/hep.28772","article-title":"First international external quality assessment for hepatitis delta virus RNA quantification in plasma","volume":"64","author":"Le Gal","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.eimce.2024.09.006_bib0060","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/apt.15521","article-title":"Long-term clinical outcomes in patients with chronic hepatitis delta: the role of persistent viraemia","volume":"51","author":"Palom","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.eimce.2024.09.006_bib0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/JCMA.0000000000000606","article-title":"Hepatitis D virus dual infection increased the risk of hepatocellular carcinoma compared with hepatitis B virus mono infection: a meta-analysis","volume":"85","author":"Changa","year":"2022","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.eimce.2024.09.006_bib0070","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3390\/cells12101413","article-title":"HDV RNA levels and progression of hepatitis delta infection: a 14 year follow up experienced in Italy","volume":"12","author":"Mangia","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.eimce.2024.09.006_bib0075","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1007\/s00705-011-1120-y","article-title":"Complete genome sequences and phylogenetic analysis of hepatitis delta viruses isolated from nine Turkish patients","volume":"156","author":"Celik","year":"2011","journal-title":"Arch Virol"},{"key":"10.1016\/j.eimce.2024.09.006_bib0080","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jhep.2020.02.030","article-title":"Chronic hepatitis D and hepatocellular carcinoma: a systematic review and meta-analysis of observational studies","volume":"73","author":"Alfayate","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.eimce.2024.09.006_bib0085","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/jvh.13899","article-title":"Epidemiology of hepatitis D virus infection in Europe: is it vanishing?","volume":"31","author":"Demirel","year":"2024","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.eimce.2024.09.006_bib0090","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3851\/IMP3161","article-title":"Decline and changing profile of hepatitis delta among injection drug users in Spain","volume":"23","author":"Aguilera","year":"2018","journal-title":"Antivir Ther"},{"key":"10.1016\/j.eimce.2024.09.006_bib0095","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/MEG.0000000000001163","article-title":"Prevalence and incidence of hepatitis delta in patients with chronic hepatitis B in Spain","volume":"30","author":"Aguilera","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.eimce.2024.09.006_bib0100","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/MEG.0000000000000795","article-title":"Prevalence and epidemiology of hepatitis D among patients with chronic hepatitis B virus infection: a report from Northern Spain","volume":"29","author":"Ordieres","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.eimce.2024.09.006_bib0105","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/hep.31214","article-title":"Long-term study of hepatitis delta virus infection at secondary care centers: the impact of viremia on liver-related outcomes","volume":"72","author":"Kamal","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.eimce.2024.09.006_bib0110","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1053\/j.gastro.2009.01.052","article-title":"A 28-year study of the course of hepatitis delta infection: a risk factor for cirrhosis and hepatocellular carcinoma","volume":"136","author":"Romeo","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.eimce.2024.09.006_bib0115","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jhep.2020.06.038","article-title":"Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta","volume":"73","author":"Roulot","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.eimce.2024.09.006_bib0120","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1053\/j.gastro.2006.01.035","article-title":"Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients","volume":"130","author":"Su","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.eimce.2024.09.006_bib0125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/liv.15745","article-title":"Five-year follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D","volume":"44","author":"Anastasiou","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.eimce.2024.09.006_bib0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hep.27102","article-title":"Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta","volume":"60","author":"Heidrich","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.eimce.2024.09.006_bib0135","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1111\/jvh.13366","article-title":"Ten-year follow-up of a randomized controlled clinical trial in chronic hepatitis delta","volume":"27","author":"Wranke","year":"2020","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.eimce.2024.09.006_bib0140","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2023.05.001","article-title":"EASL clinical practice guidelines on hepatitis delta virus","volume":"79","year":"2023","journal-title":"J Hepatol"}],"container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X24002089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X24002089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T09:25:25Z","timestamp":1730712325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2529993X24002089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2529993X24002089"],"URL":"https:\/\/doi.org\/10.1016\/j.eimce.2024.09.006","relation":{},"ISSN":["2529-993X"],"issn-type":[{"type":"print","value":"2529-993X"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and clinical-epidemiological characteristics of chronic hepatitis due to hepatitis delta virus on Gran Canaria Island","name":"articletitle","label":"Article Title"},{"value":"Enfermedades infecciosas y microbiologia clinica (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimce.2024.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2024.06.008","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}